Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.
about
Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancerCombination chemotherapy versus single agent chemotherapy during preoperative chemoradiation for resectable rectal cancerRevised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomesFive fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer.Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum.Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.Colorectal cancer: from epidemiology to current treatment.Etoposide sensitizes CT26 colorectal adenocarcinoma to radiation therapy in BALB/c mice.A phase II study of oxaliplatin with 5-FU/folinic acid and concomitant radiotherapy as a preoperative treatment in patients with locally advanced rectal cancerEarly changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice.Developments in treatment of primary irresectable rectal cancer.Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysisPreoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer GroupPathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials.Comparison of conventional and three-dimensional conformal CT planning techniques for preoperative chemoradiotherapy for locally advanced rectal cancer.Preoperative versus postoperative treatment for locally advanced rectal carcinoma.Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study.Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II studyA phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) studyIntensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancerA review of the role of capecitabine in the treatment of colorectal cancer.Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerationsStratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status.Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard.Potential benefits of integration of therapies with chemoradiation in rectal cancer.Oxaliplatin-based chemotherapy in the management of colorectal cancer.Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapyDPYD, TYMS, TYMP, TK1, and TK2 genetic expressions as response markers in locally advanced rectal cancer patients treated with fluoropyrimidine-based chemoradiotherapy.Adjuvant therapy for rectal cancerMultidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapyThe role of neoadjuvant therapy in sphincter-saving surgery for mid and distal rectal cancer.Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy.Locally advanced rectal cancer: a comparison of management strategies.Toward the non-surgical management of locally advanced rectal cancer.Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART).Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer.Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064).
P2860
Q24186443-D3986531-725B-451E-82B1-F9C9B794C135Q24235103-299A84C6-3FD3-4BD3-9CD5-F0526C444C7DQ33627785-8B2088A3-8AA8-435A-843D-A20BDEA609F3Q33637997-8B555150-E1FC-48F3-845C-516E96723A23Q34098024-C0661E4B-2879-4818-B687-5E01DFFBB30AQ34344547-64DE010E-44FB-4FC7-B819-F555F7E31A25Q34844579-240DFF9C-72AE-4B9B-8BDF-E38A0441BBDCQ35435861-115EBE2F-1CD2-4421-8333-D43E862B00E4Q35691981-AFC32858-DC38-45BE-90D5-157DE4018EB0Q35812742-F4BED57A-F956-4913-AA47-FC2F7EDB6D59Q35937087-91850687-1F70-4198-88EB-BF037B76180CQ36056754-1D942146-CA6D-4DCF-8CEE-3D3196965F66Q36087573-463BD9A6-60EB-49FE-BF00-999EFF434ED0Q36263852-7D12169A-7596-4C09-988E-9B787FC64616Q36325238-64487A88-4D19-41A6-9A66-7B0ECC39324DQ36429439-EDB8FA5D-ACF1-4B7E-B8D5-1F10095F712AQ36487139-1AE9D404-17CC-469B-B93D-E455DF743E2EQ36608578-546875EF-BCF8-4B18-9811-D134150B2DA3Q36614369-3F7F6334-CACC-4847-8A1E-AFE868EA5967Q36615549-E427A1C6-6E5A-432A-A53A-C0131453F4E5Q36616544-F8386340-2785-4910-A579-E5EFFAE3B267Q36661290-2D922268-3CA7-4137-A20F-4CB80C7F63F2Q36984204-5290536B-1EAA-48D4-AC15-E4768DE37CDCQ37072492-55BD449E-835B-4D3C-BD73-2D157500AD4EQ37077330-5216A4C5-BEDA-442B-A515-98BFAF6D8F29Q37153308-6AD2CFA5-896C-460A-AC3D-984A98B3DDF1Q37242664-1A2C2073-2739-41AD-9808-A81C96340567Q37271984-D3184A93-CE9D-4B1C-9F3B-9932F0786A59Q37450200-FD919F8C-18A0-47AB-9BBA-CB4C1CEA1D68Q37462241-4490CCBE-E071-4E9F-A64E-5B5ACEB81CD7Q37565629-F1927FD0-3BAF-4EAD-AF4A-BED94F496256Q37602735-06D29C8F-7A2E-431A-8E5B-CE9AC0AC9ACBQ37621525-0AAEBF85-D9BE-41AE-BBE0-9281E370E99FQ37688397-792D4CFB-63A1-4D1A-9D5D-74EBD3B39BF5Q37895253-D90AFE64-0747-457C-97BC-07C4874122A1Q37998384-B9A36F61-B42C-41F8-9CCB-BFD98FBC3097Q44197593-105C8CCE-4DAC-4333-A463-7FA47E88F216Q46747924-3956B716-A68A-4D22-A6A6-D9F62339ED31Q46876686-B30D5BEB-407E-44A9-B1ED-84C71C8B2135Q47718910-0B505B03-2074-432F-B53A-36EBD32AA4E3
P2860
Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Preoperative concurrent chemor ...... the Lyon R0-04 phase II trial.
@en
Preoperative concurrent chemor ...... the Lyon R0-04 phase II trial.
@nl
type
label
Preoperative concurrent chemor ...... the Lyon R0-04 phase II trial.
@en
Preoperative concurrent chemor ...... the Lyon R0-04 phase II trial.
@nl
prefLabel
Preoperative concurrent chemor ...... the Lyon R0-04 phase II trial.
@en
Preoperative concurrent chemor ...... the Lyon R0-04 phase II trial.
@nl
P2093
P356
P1476
Preoperative concurrent chemor ...... the Lyon R0-04 phase II trial.
@en
P2093
Chantal Nemoz
Françoise Mornex
Gilles Freyer
Jean-Pierre Gérard
Nicolas Barbet
Olivier Chapet
Pascale Romestaing
Patrice Adeleine
Régis Coquard
P304
P356
10.1200/JCO.2003.10.045
P407
P577
2003-03-01T00:00:00Z